Safety and efficacy of erythropoiesis-stimulating agents in critically ill patients admitted to the intensive care unit: a systematic review and meta-analysis.
Edward LittonPeter LathamJulia InmanJingjing LuoPeter AllanPublished in: Intensive care medicine (2019)
In heterogenous populations of critically ill adults, evidence from RCTs of mainly low or unclear quality, suggests that ESA therapy may decrease mortality.